OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 3
Data from combined, up to 2021-03-20.
| Vaccinated at 2021-03-20 (%) | Vaccinated at 2021-03-20 (n) | Population | Vaccinated at 2021-03-13 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 48.7% | 959,980 | 1,970,192 | 48.6% | 0.1% |
| Sex | Female | 48.8% | 512,743 | 1,049,629 | 48.7% | 0.1% |
| Male | 48.6% | 447,237 | 920,563 | 48.5% | 0.1% | |
| Ethnicity | White - British | 49.7% | 600,733 | 1,208,025 | 49.6% | 0.1% |
| White - Irish | 43.2% | 7,217 | 16,688 | 43.0% | 0.2% | |
| White - Any other White background | 39.6% | 17,080 | 43,120 | 39.4% | 0.2% | |
| Mixed - White and Black Caribbean | 39.9% | 861 | 2,156 | 39.6% | 0.3% | |
| Mixed - White and Black African | 38.0% | 434 | 1,141 | 37.4% | 0.6% | |
| Mixed - White and Asian | 39.8% | 518 | 1,302 | 39.8% | 0.0% | |
| Mixed - Any other mixed background | 40.1% | 910 | 2,268 | 39.5% | 0.6% | |
| Asian or Asian British - Indian | 39.7% | 10,150 | 25,543 | 39.5% | 0.3% | |
| Asian or Asian British - Pakistani | 41.0% | 4,340 | 10,584 | 40.1% | 0.9% | |
| Asian or Asian British - Bangladeshi | 43.5% | 1,267 | 2,912 | 42.5% | 1.0% | |
| Asian or Asian British - Any other Asian background | 37.2% | 4,256 | 11,438 | 37.0% | 0.2% | |
| Black or Black British - Caribbean | 36.3% | 4,151 | 11,424 | 35.6% | 0.7% | |
| Black or Black British - African | 32.1% | 2,576 | 8,036 | 31.3% | 0.8% | |
| Black or Black British - Any other Black background | 35.2% | 616 | 1,750 | 34.8% | 0.4% | |
| Other ethnic groups - Chinese | 36.8% | 1,169 | 3,178 | 36.3% | 0.4% | |
| Other ethnic groups - Any other ethnic group | 40.1% | 2,555 | 6,377 | 39.6% | 0.4% | |
| Patients with any other ethnicity code | 49.3% | 136,157 | 276,339 | 49.2% | 0.1% | |
| Ethnicity not stated | 48.3% | 5,656 | 11,718 | 48.1% | 0.1% | |
| Ethnicity not recorded | 48.8% | 159,236 | 326,088 | 48.7% | 0.1% | |
| Ethnicity (broad categories) | White | 49.3% | 625,044 | 1,267,847 | 49.2% | 0.1% |
| Mixed | 39.7% | 2,737 | 6,888 | 39.4% | 0.3% | |
| South Asian | 39.7% | 20,027 | 50,498 | 39.2% | 0.4% | |
| Black | 34.7% | 7,357 | 21,231 | 34.0% | 0.7% | |
| Other | 39.0% | 3,731 | 9,555 | 38.6% | 0.4% | |
| Unknown | 49.0% | 301,056 | 614,152 | 48.9% | 0.1% | |
| Index of Multiple Deprivation | 1 (most deprived) | 47.7% | 123,879 | 259,721 | 47.4% | 0.3% |
| 2 | 47.1% | 156,667 | 332,640 | 46.9% | 0.2% | |
| 3 | 48.8% | 204,750 | 419,454 | 48.7% | 0.1% | |
| 4 | 49.0% | 225,232 | 459,669 | 48.9% | 0.1% | |
| 5 (least deprived) | 49.9% | 241,437 | 483,392 | 49.9% | 0.1% | |
| Unknown | 52.2% | 7,987 | 15,288 | 52.2% | 0.1% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 49.5% | 573,783 | 1,159,410 | 49.3% | 0.1% |
| Patients with Immunosuppression | 49.3% | 42,238 | 85,743 | 49.1% | 0.1% | |
| Patients with CKD | 49.7% | 160,538 | 323,316 | 49.5% | 0.1% | |
| Patients who have Chronic Respiratory Disease | 50.4% | 113,022 | 224,168 | 50.3% | 0.2% | |
| Patients with Diabetes | 49.2% | 180,663 | 367,003 | 49.0% | 0.2% | |
| Patients with Chronic Liver disease | 48.7% | 25,431 | 52,178 | 48.6% | 0.1% | |
| Patients with CNS Disease (including Stroke/TIA) | 51.8% | 110,327 | 212,828 | 51.6% | 0.2% | |
| Patients with Chronic heart disease | 49.8% | 294,448 | 590,891 | 49.7% | 0.1% | |
| Patients with Asplenia or Dysfunction of the Spleen | 49.5% | 8,470 | 17,122 | 49.4% | 0.1% | |
| Patients with Wider Learning Disability | 58.7% | 1,365 | 2,324 | 57.8% | 0.9% | |
| Patients with Severe Mental Health | 51.8% | 8,162 | 15,750 | 51.3% | 0.5% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 49.9% | 153,314 | 307,188 | 49.7% | 0.2% |
| Patients with Morbid Obesity | 51.8% | 24,724 | 47,698 | 51.6% | 0.2% | |
| Patients who are pregnant | 53.1% | 119 | 224 | 53.1% | 0.0% |